Loading...
Tissue cross-reactivity studies of CPGJ701 in humans, cynomolgus monkeys and Sprague-Dawley rats and correlation analysis with in vivo toxicity
BACKGROUND: CPGJ701 is a recombinant humanized anti-human epidermal growth factor receptor-2 (HER2) monoclonal antibody-derivative of the cytotoxic agent maytansine (DM1) conjugate for the treatment of HER2-positive metastatic breast cancer. Tissue cross-reactivity (TCR) studies of CPGJ701 in a comp...
Na minha lista:
| Udgivet i: | Ann Transl Med |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7186683/ https://ncbi.nlm.nih.gov/pubmed/32355769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2020.02.106 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|